Printer Friendly

SweeGen Inc announces FDA No Objection Letter for BESTEVIA Reb E stevia leaf sweetener.

Global Banking News-June 26, 2019-SweeGen Inc announces FDA No Objection Letter for BESTEVIA Reb E stevia leaf sweetener

(C)2019 ENPublishing - http://www.enpublishing.co.uk

Sweetener company SweeGen Inc said on Tuesday that it has received the GRAS (Generally Recognized As Safe) No Objection Letter for BESTEVIA Rebaudioside E (Reb E) stevia leaf sweetener for use in foods from the US Food and Drug Administration (FDA).

According to the company, BESTEVIA e+ shows great success in reducing sugar and artificial sweeteners in many applications, such as beverage, dairy, sports nutrition, condiments and bakeries. BESTEVIA e+ provides a clean, sugar-like taste at a price equivalent to sugar.

The company added that the BESTEVIA Reb E, a non-caloric, high-purity stevia sweetener, is produced from the stevia leaf through the US FDA evalueted non-GMO bioconversion process.

Following the US FDA No Objection Letter, the company added that will continue to pursue global approvals of the BESTEVIA Rebaudioside E (Reb E) stevia leaf sweetener for use in foods.

((Distributed via M2 Communications - http://www.m2.com))

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Global Banking News (GBN)
Date:Jun 26, 2019
Words:173
Previous Article:Greenlane wins new CAD3.4m biogas upgrading contract in Canada.
Next Article:International Petroleum commences drilling programme in Malaysia.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |